Tempus AI’s moat on its healthcare diagnostics platform is being built around three main product lines, although revenue is mainly being driven by Genomics and Data. Diagnostic testing and ...

Tempus AI (TEM) is soaring 13% today after investment bank TD Cowen reinstated coverage of the shares with a Buy rating. TEM provides next generation sequencing diagnostics, polymerase chain ...

In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against other firms that posted double-digit gains on Thursday. Wall Street’s main indices finished in ...

Tempus AI's scalable data ecosystem and path to profitability ... that have the potential to provide it with a competitive moat (we shall see – the same thesis was valid for Invitae and it ...

Tempus AI shares surged more than 35% on Tuesday after former House Speaker Nancy Pelosi disclosed call options expiring in 2026. Several AI-related stocks are rising Wednesday after U.S ...

Shares of Tempus AI stock opened at $89.44 on Wednesday. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. Tempus AI has a 12 month low of $22.89 ...

Tempus AI, Inc. Class A (TEM – Research Report) received a Hold rating and price target from William Blair analyst Andrew Brackmann today. The company’s shares closed yesterday at $89.44.

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared to its daily average volume of about 5.67 million. All thanks to three ...

We recently published a list of 10 Firms Post Double-Digit Gains on Thursday. In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against other firms that posted ...

Tempus AI (TEM) is soaring 13% today after investment bank TD Cowen reinstated coverage of the shares with a Buy rating. TEM provides next generation sequencing diagnostics, polymerase chain reaction ...